Foghorn Therapeutics Inc
FHTX
$3.50-2.78%
End of day · as of Sep 26, 2026, 3:15 AM ET
Mkt cap
$237.79M
EV/Sales
5.08
P/E ratio
N/A
FY2025 Revenue
$30.91M
EPS (TTM)
$-0.99
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-240.33%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
Latest reported FHTX revenue for 2025-12-31 was $30.9M. Net income was -$74.3M. Revenue was up 36.8% from 2024-12-31 to 2025-12-31. FHTX currently screens at market cap $237.8M.
Use this FHTX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full FHTX income, balance, and cash tables.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company in the Healthcare sector.
Latest cached Foghorn Therapeutics Inc (FHTX) revenue for Dec 31, 2025 was $30.9M. Net income was -$74.3M. Statements: https://lician.com/financials/fhtx
Foghorn Therapeutics Inc (FHTX) market capitalization is $237.8M on the latest cached snapshot.
Foghorn Therapeutics Inc (FHTX) cached previous close $3.60; day range $3.47 – $3.66; volume 525,313. Session quote: https://lician.com/quote/fhtx
Foghorn Therapeutics Inc (FHTX) latest cached earnings event is "FHTX earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached FHTX filing is 8-K · Oct 1, 2026. Filings: https://lician.com/sec/fhtx